Results of a phase II, open-label pilot study evaluating the safety and activity of liposomal irinotecan (Nal-IRI) in combination with 5-FU and oxaliplatin (NALIRIFOX) in preoperative treatment of pancreatic adenocarcinoma (NEO-Nal-IRI study).
| Autor: | George, Thomas J., Rogers, Sherise C., Nassour, Ibrahim, Sahin, Ilyas, Ramnaraign, Brian Hemendra, Fabregas, Jesus, Hitchcock, Kathryn, Lin, Tuo, Liu, Gonghao, Zlotecki, Robert, Kayaleh, Omar Roger, Turk, Anita Ahmed, Fan, Z. Hugh, Russell, Karen Bullock, DeRemer, David L., Lee, Ji-Hyun, Hughes, Steven J. |
|---|---|
| Zdroj: | Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p655-655, 117p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|